Ladenburg Thalmann Financial Services
http://www.ladenburg.comLadenburg Thalmann Financial Services, Inc. (AMEX: LTS) provides retail and institutional securities brokerage, investment banking, investment activities, and asset management services as well as equity research. In May of 2008, Ladenburg Thalmann acquired Punk Ziegel & Company to strengthen its trading, research, and investment banking departments. Ladenburg Thalmann is headquartered in Miami, FL.
View Older Stories View More Recent Stories
-
Evaxion Biotech A/S (EVAX) IPO Opens Flat
-
Evaxion Biotech A/S (EVAX) Prices 3M ADS IPO at $10/ADS
-
Evaxion Biotech Announces Pricing of Initial Public Offering
-
Dynex Capital (DX) PT Raised to $19 at Ladenburg Thalmann, Following Earnings
-
Big Cypress Acquisition Corp. Announces Separate Trading of its Shares of Common Stock and Redeemable Warrants Commencing February 9, 2021
-
Big Cypress Acquisition Corp. Announces Separate Trading of its Shares of Common Stock and Redeemable Warrants Commencing February 9, 2021
-
Terra Income Fund 6, Inc. Prices Public Offering of $34.75 Million 7.00% Notes Due 2026
-
Advisor Group Launches New Advisor Engagement Team, Spearheaded By Wealth Management Industry Leader Erinn Ford
-
Krystal Biotech (KRYS) Prices 1.923M Share Upsized Common Offering at $65/Sh
-
Krystal Biotech Announces Pricing of Upsized $125 Million Public Offering of Common Stock
-
Trinity Capital Inc. Announces Closing of Initial Public Offering and Full Exercise of Underwriters' Option to Purchase Additional Shares
-
Terra Income Fund 6, Inc. Announces Offering of Notes
-
Brookline Capital Acquisition Corp. Completes Closing of $57,500,000 Initial Public Offering
-
Brookline Capital Acquisition Corp. Completes Closing of $57,500,000 Initial Public Offering
-
Helius Medical Technologies, Inc. Announces Closing of $11.0 Million Underwritten Public Offering and Full Exercise of Over-Allotment Option
-
Helius Medical Technologies, Inc. Announces Closing of $11.0 Million Underwritten Public Offering and Full Exercise of Over-Allotment Option
-
Catabasis Pharmaceuticals Announces Acquisition of Quellis Biosciences Inc.
-
Trinity Capital Inc. (TRIN) Prices 7.375M Share IPO at $14/Sh
-
Brookline Capital Acquisition Corp. (BCAC) Prices 5M Unit IPO at $10/Unit
-
Trinity Capital Inc. Prices Initial Public Offering
-
Brookline Capital Acquisition Corp. Announces Pricing of $50,000,000 Initial Public Offering
-
Brookline Capital Acquisition Corp. Announces Pricing of $50,000,000 Initial Public Offering
-
Lipocine Closes Underwritten Public Offering Of Common Stock
-
Helius Medical Technologies, Inc. Announces Pricing of $9.6 Million Underwritten Public Offering Priced At Market
-
Helius Medical Technologies, Inc. Announces Pricing of $9.6 Million Underwritten Public Offering Priced At Market
-
Armata Pharmaceuticals Announces $20 Million Investment to Support Advancement of the Company's Bacteriophage Development Programs
-
Bionano Genomics (BNGO) PT Raised to $14 at Ladenburg Thalmann (Earlier)
-
Lipocine (LPCN) Prices $25 Million Underwritten Public Offering Of Common Stock
-
Lipocine Prices $25 Million Underwritten Public Offering Of Common Stock
-
UPDATE: Ladenburg Thalmann Downgrades IZEA, Inc (IZEA) to Sell, 'Current Valuation Well Above Current Fundamentals'
-
Monroe Capital Corporation Closes Offering of $130 Million 4.75% Notes Due 2026
-
Monroe Capital Corporation Closes Offering of $130 Million 4.75% Notes Due 2026
-
B. Riley Financial Announces Closing of $200 Million Offering of Senior Notes Due 2028
-
Bionano Genomics Announces Closing of $230 Million Underwritten Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares
-
Trinity Capital Inc. (TRIN) Announces Proposed 7.547M Share IPO Between $13.50-$15.50/Sh
-
Trinity Capital Inc. Announces Proposed Initial Public Offering
-
B. Riley Financial Announces Pricing of $200 Million Offering of Senior Notes Due 2028
-
Ladenburg Thalmann Downgrades TransEnterix (TRXC) to Neutral
-
B. Riley Financial Announces Offering of $100 Million Senior Notes Due 2028 and "BBB+" Rating from Egan-Jones
-
BioNano Genomics, Inc. (BNGO) Prices 33.3M Share Common Stock Offering at $6/Each
-
Bionano Genomics Announces Pricing of $200 Million Underwritten Public Offering of Common Stock
-
BioNano Genomics, Inc. (BNGO) to Offer Common Stock
-
Bionano Genomics Announces Proposed Underwritten Public Offering of Common Stock
-
Orthofix International (OFIX) PT Raised to $50.25 at Ladenburg Thalmann
-
Monroe Capital Corporation Prices Offering of $130 Million 4.75% Notes Due 2026
-
Monroe Capital Corporation Prices Offering of $130 Million 4.75% Notes Due 2026
-
Franchise Group, Inc. Closes Preferred Stock Offering
-
Newtek Business Services Corp.’s CEO, Barry Sloane, Comments on the Company’s $100 Million Public Offering of 5.50% Notes Due 2026
-
Newtek Business Services Corp. Prices a Public Offering of 5.50% Notes Due 2026
-
Newtek Business Services Corp.’s CEO, Barry Sloane, Comments on the Company’s $100 Million Public Offering of 5.50% Notes Due 2026

